aod9604 human clinical trial results weight loss efficacy AOD-9604 Safety Profile: What Trials Show AOD 9604 vs. Semaglutide: A
Description
What they found: No serious adverse events triggered by AOD-9604 The most frequent side effects: headache (~5 %), occasional fatigue, at the same frequency as placebo No changes in IGF-1 levels, glycemia, blood pressure, heart rate No signals of cardiovascular, hepatic or renal toxicity Safety profile comparable to placebo Why it matters: From a safety perspective, AOD-9604 is one of the safest peptides in the clinical registry
Evidence for these combinations comes from the individual compound data
Cell 48, 242253
This combination helps support energy metabolism, nervous system health, and red blood cell production making it one of the more well-rounded liquid B12 supplements in its price range
Certain medical conditions should also be noted, such as kidney disease, low potassium and other nutritional deficiencies
By supporting the creation of healthy red blood cells, injections directly combat anemia and improve oxygen delivery throughout the body
